Watch the editorial comment by Prof. Dr. Paolo Gontero on biomarker statements in the new EAU 2022 guidelines.
Prof. Dr. Paolo Gontero is Professor of Urology at the University of Turin School of Medicine and Chairmen of the Division of Urology at the San Giovanni Battista (Molinette) Hospital, Italy.
Prof. Dr. Gontero is the Chair of the European guidelines for non-muscle-invasive bladder cancer (TaT1 and CIS).
Godelieve is a 77-year-old retired teacher. One year ago, she underwent TURBT of 1 small papillary tumour of 1 cm at the right bladder wall, which was detected during a cystoscopic examination for painless haematuria. The pathology report indicated pTa grade 2,...
Improving detection of high-grade recurrences missed by WLC using a urinary biomarkerReviewed by Marek Babjuk Surveillance for non-muscle-invasive bladder cancer (NMIBC) relies on routine white-light cystoscopy (WLC) and urinary cytology as the diagnostic...
Peter, a 72-year-old retired engineer, was diagnosed with T1 high-grade (HG) non-muscle-invasive bladder cancer (NMIBC) 18 months ago. Following a successful transurethral resection of the bladder tumour (TURBT) and re-TURBT without further pathology, he received a...